Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11248046 Claudin 6 antibodies and uses thereof

Patent 11248046 was granted and assigned to INTEGRAL MOLECULAR, INC on February, 2022 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

112480460

Patent Inventor Names

Thomas Charpentier0

Trevor Barnes0

Benjamin Doranz0

Brad Screnci0

Joseph Rucker0

Lewis J. Stafford0

Ross Chambers0

Date of Patent

February 15, 2022

Patent Application Number

167900660

Date Filed

February 13, 2020

Patent Citations

‌

US Patent 10336818 Fc variants with altered binding to FcRn

‌

US Patent 10053511 Anti-claudin antibodies and methods of use

‌

US Patent 10604568 Diagnosis and therapy of cancer involving cancer stem cells

Patent Citations Received

Patent Primary Examiner

‌

Adam Weidner

Patent abstract

Antibodies and compositions against Claudin 6 and uses thereof are provided.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11248046 Claudin 6 antibodies and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API